DEVELOPMENT AND EVALUATION OF SBA-15 MESOPOROUS SILICA NANOPARTICLES FOR BIOAVAILABILITY ENHANCEMENT OF RITONAVIR. Int. Res. J. Pharm. 2018, 9 (3), 13-19.